Epidemiology of primary Sjögren's syndrome in a french multiracial/multiethnic area

Arthritis Care and Research

Volumn 66, Issue 3, 2014, Pages 454-463

  Maldini, Carla ^a   Seror, Raphaèle ^b   Fain, Olivier ^c   Dhote, Robin ^c   Amoura, Zahir ^d   De Bandt, Michel ^e   Delassus, Jean Luc ^e   Falgarone, Géraldine ^c   Guillevin, Loïc ^f   Le Guern, Véronique ^f   Lhote, François ^g   Meyer, Olivier ^h   Ramanoelina, Jacky ⁱ   Sacré, Karim ^h   Uzunhan, Yurdagul ^c   Leroux, Jean Louis ^j   Mariette, Xavier ^b   Mahr, Alfred ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c UNIVERSITÉ PARIS 13   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e Centre Hospitalier Robert Ballanger CHRB   (France)

^f université Paris Cité   (France)

^g DELAFONTAINE HOSPITAL   (France)

^h BICHAT HOSPITAL   (France)

ⁱ Cardiology Department   (France)

^j Service Médical Assurance Maladie   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

LA ANTIBODY; RO ANTIBODY;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRY EYE; ETHNIC DIFFERENCE; FEMALE; FRANCE; HEALTH SURVEY; HUMAN; HYPERGAMMAGLOBULINEMIA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MINOR SALIVA GLAND; POPULATION RESEARCH; PREVALENCE; RACE DIFFERENCE; SALIVARY GLAND BIOPSY; SJOEGREN SYNDROME; XEROSTOMIA;

ADULT; AGED; CROSS-SECTIONAL STUDIES; FEMALE; FRANCE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; SJOGREN'S SYNDROME;

EID: 84896840176     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.22115     Document Type: Article

References (53)

1. Kassan SS, Moutsopoulos HM,. Clinical manifestations and early diagnosis of Sjogren syndrome. Arch Intern Med 2004; 164: 1275-84.
2. Ramos-Casals M, Brito-Zeron P, Siso-Almirall A, Bosch X,. Primary Sjogren syndrome. BMJ 2012; 344: e3821.
3. Theander E, Henriksson G, Ljungberg O, Mandl T, Manthorpe R, Jacobsson LT,. Lymphoma and other malignancies in primary Sjogren's syndrome: a cohort study on cancer incidence and lymphoma predictors. Ann Rheum Dis 2006; 65: 796-803.
4. Zintzaras E, Voulgarelis M, Moutsopoulos HM,. The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch Intern Med 2005; 165: 2337-44.
5. Alamanos Y, Tsifetaki N, Voulgari PV, Venetsanopoulou AI, Siozos C, Drosos AA,. Epidemiology of primary Sjogren's syndrome in north-west Greece, 1982-2003. Rheumatology (Oxford) 2006; 45: 187-91.
6. Pillemer SR, Matteson EL, Jacobsson LT, Martens PB, Melton LJ 3rd, O'Fallon WM, et al. Incidence of physician-diagnosed primary Sjogren syndrome in residents of Olmsted County, Minnesota. Mayo Clin Proc 2001; 76: 593-9.
7. Plesivcnik Novljan M, Rozman B, Hocevar A, Grmek M, Kveder T, Tomsic M,. Incidence of primary Sjogren's syndrome in Slovenia. Ann Rheum Dis 2004; 63: 874-6.
8. Yu KH, See LC, Kuo CF, Chou IJ, Chou MJ,. Prevalence and incidence in patients with autoimmune rheumatic diseases: a nationwide population-based study in Taiwan. Arthritis Care Res (Hoboken) 2013; 65: 244-50.
9. Birlik M, Akar S, Gurler O, Sari I, Birlik B, Sarioglu S, et al. Prevalence of primary Sjogren's syndrome in Turkey: a population-based epidemiological study. Int J Clin Pract 2009; 63: 954-61.
10. Goransson LG, Haldorsen K, Brun JG, Harboe E, Jonsson MV, Skarstein K, et al. The point prevalence of clinically relevant primary Sjogren's syndrome in two Norwegian counties. Scand J Rheumatol 2011; 40: 221-4.
11. Miyasaka N,. Epidemiology and pathogenesis of Sjogren's syndrome. Nippon Rinsho 1995; 53: 2367-70. In Japanese.
12. Thomas E, Hay EM, Hajeer A, Silman AJ,. Sjogren's syndrome: a community-based study of prevalence and impact. Br J Rheumatol 1998; 37: 1069-76.
13. Tomsic M, Logar D, Grmek M, Perkovic T, Kveder T,. Prevalence of Sjogren's syndrome in Slovenia. Rheumatology (Oxford) 1999; 38: 164-70.
14. Trontzas PI, Andrianakos AA,. Sjogren's syndrome: a population based study of prevalence in Greece. The ESORDIG study [letter]. Ann Rheum Dis 2005; 64: 1240-1.
15. Zhang NZ, Shi CS, Yao QP, Pan GX, Wang LL, Wen ZX, et al. Prevalence of primary Sjogren's syndrome in China. J Rheumatol 1995; 22: 659-61.
16. Piram M, Maldini C, Mahr A,. Effect of race/ethnicity on risk, presentation and course of connective tissue diseases and primary systemic vasculitides. Curr Opin Rheumatol 2012; 24: 193-200.
17. Mahr A, Guillevin L, Poissonnet M, Ayme S,. Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate. Arthritis Rheum 2004; 51: 92-9.
18. Le Guern V, Mahr A, Mouthon L, Jeanneret D, Carzon M, Guillevin L,. Prevalence of systemic sclerosis in a French multi-ethnic county. Rheumatology (Oxford) 2004; 43: 1129-37.
19. Mahr A, Belarbi L, Wechsler B, Jeanneret D, Dhote R, Fain O, et al. Population-based prevalence study of Behcet's disease: differences by ethnic origin and low variation by age at immigration. Arthritis Rheum 2008; 58: 3951-9.
20. AFGS: Association Française du Gougerot Sjögren et des Syndromes secs. 2008-2012. Evolution du nombre d'adhérents. URL: http://www.afgs-syndromes-secs.org/adherents.php?titre=Evolution.
21. Disparités territoriales des dépenses de santé: le rôle des facteurs de demande et d'offre de soins. URL: http://www.sante.gouv.fr/IMG/pdf/eclairage-disparites-cns2009.pdf.
22. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61: 554-8.
23. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
24. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
25. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-90.
26. LeRoy EC, Medsger TA Jr., Criteria for the classification of early systemic sclerosis. J Rheumatol 2001; 28: 1573-6.
27. Ahmad OB, Boschi-Pinto C, Lopez A, Murray C, Lozano R, Inoue M, et al. Age standardization of rates: a new WHO standard. Geneva: World Health Organization; 2001.
28. Baillargeon S, Rivest LP,. Rcapture: loglinear models for capture-recapture in R. J Stat Softw 2007; 19: 1-31.
29. Baldini C, Talarico R, Tzioufas AG, Bombardieri S,. Classification criteria for Sjogren's syndrome: a critical review. J Autoimmun 2012; 39: 9-14.
30. Shiboski SC, Shiboski CH, Criswell LA, Baer AN, Challacombe S, Lanfranchi H, et al. American College of Rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken) 2012; 64: 475-87.
31. Galvez J, Saiz E, Lopez P, Pina MF, Carrillo A, Nieto A, et al. Diagnostic evaluation and classification criteria in Sjogren's syndrome. Joint Bone Spine 2009; 76: 44-9.
32. Bolstad AI, Jonsson R,. Genetic aspects of Sjogren's syndrome. Arthritis Res 2002; 4: 353-9.
33. Cobb BL, Lessard CJ, Harley JB, Moser KL,. Genes and Sjogren's syndrome. Rheum Dis Clin North Am 2008; 34: 847-68.
34. Scofield RH,. Genetics of systemic lupus erythematosus and Sjogren's syndrome. Curr Opin Rheumatol 2009; 21: 448-53.
35. Martel C, Gondran G, Launay D, Lalloue F, Palat S, Lambert M, et al. Active immunological profile is associated with systemic Sjogren's syndrome. J Clin Immunol 2011; 31: 840-7.
36. Gottenberg JE, Busson M, Loiseau P, Cohen-Solal J, Lepage V, Charron D, et al. In primary Sjögren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response. Arthritis Rheum 2003; 48: 2240-5.
37. Corrao G, Bagnardi V, Vittadini G, Favilli S,. Capture-recapture methods to size alcohol related problems in a population. J Epidemiol Community Health 2000; 54: 603-10.
38. Aaron DJ, Chang YF, Markovic N, LaPorte RE,. Estimating the lesbian population: a capture-recapture approach. J Epidemiol Community Health 2003; 57: 207-9.
39. Orton H, Rickard R, Miller L,. Using active medical record review and capture-recapture methods to investigate the prevalence of Down syndrome among live-born infants in Colorado. Teratology 2001; 64 Suppl 1: S14-9.
40. Hook EB, Regal RR,. Accuracy of alternative approaches to capture-recapture estimates of disease frequency: internal validity analysis of data from five sources. Am J Epidemiol 2000; 152: 771-9.
41. Bowman SJ, Ibrahim GH, Holmes G, Hamburger J, Ainsworth JR,. Estimating the prevalence among Caucasian women of primary Sjogren's syndrome in two general practices in Birmingham, UK. Scand J Rheumatol 2004; 33: 39-43.
42. Dafni UG, Tzioufas AG, Staikos P, Skopouli FN, Moutsopoulos HM,. Prevalence of Sjogren's syndrome in a closed rural community. Ann Rheum Dis 1997; 56: 521-5.
43. Kabasakal Y, Kitapcioglu G, Turk T, Oder G, Ulusoy R, Mete N, et al. Prevalence of Sjögren's syndrome (SS) in Izmir, Turkey [abstract]. Ann Rheum Dis 2004; 63: 503.
44. Strickland RW, Tesar JT, Berne BH, Hobbs BR, Lewis DM, Welton RC,. The frequency of sicca syndrome in an elderly female population. J Rheumatol 1987; 14: 766-71.
45. Bjerrum KB,. Keratoconjunctivitis sicca and primary Sjogren's syndrome in a Danish population aged 30-60 years. Acta Ophthalmol Scand 1997; 75: 281-6.
46. Drosos AA, Andonopoulos AP, Costopoulos JS, Papadimitriou CS, Moutsopoulos HM,. Prevalence of primary Sjogren's syndrome in an elderly population. Br J Rheumatol 1988; 27: 123-7.
47. Haugen AJ, Peen E, Hulten B, Johannessen AC, Brun JG, Halse AK, et al. Estimation of the prevalence of primary Sjogren's syndrome in two age-different community-based populations using two sets of classification criteria: the Hordaland Health Study. Scand J Rheumatol 2008; 37: 30-4.
48. Hochberg MC, Schein OD, Munoz B, Anhalt G, Provost TT, West S,. The prevalence of dry eye, dry mouth, autoimmunity and primary Sjogren's syndrome in the general population [abstract]. Arthritis Rheum 1996; 39 Suppl: S66.
49. Jacobsson LT, Axell TE, Hansen BU, Henricsson VJ, Larsson A, Lieberkind K, et al. Dry eyes or mouth: an epidemiological study in Swedish adults, with special reference to primary Sjogren's syndrome. J Autoimmun 1989; 2: 521-7.
50. Eaton WW, Rose NR, Kalaydjian A, Pedersen MG, Mortensen PB,. Epidemiology of autoimmune diseases in Denmark. J Autoimmun 2007; 29: 1-9.
51. Sardu C, Cocco E, Mereu A, Massa R, Cuccu A, Marrosu MG, et al. Population based study of 12 autoimmune diseases in Sardinia, Italy: prevalence and comorbidity. PLoS One 2012; 7: e32487.
52. Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM, et al. Preliminary criteria for the classification of Sjögren's syndrome: results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993; 36: 340-7.
53. Homma M, Tojo T, Akizuki M, Yamagata H,. Criteria for Sjogren's syndrome in Japan. Scand J Rheumatol 1986; 61 Suppl: 26-7.